Explore PMOS Research
Search 20,710 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies5,121–5,140 of 20,710
All studies
Efficacy of Metformin in Treating Complications Associated with Polycystic Ovary Syndrome (PCOS)
Combined Oral Contraceptives for Polycystic Ovary Syndrome: Pro and Contra (Review)
Circulating Anti-mullerian Hormone as Predictor of Ovarian Response to Simple Induction of Ovulation in Women with Polycystic Ovary Syndrome
IDENTIFICATION OF KEY GENES ASSOCIATED WITH PCOS (POLY CYSTIC OVARIAN SYNDROME) AND ENDOMETRIAL/OVARIAN CANCER THROUGH BIOINFORMATICS
Effectiveness of Class Imbalance Treatment for Diagnosis of PCOS Using Machine Learning Models: A Comparative Study
Clinicians perspectives on nutritional supplementation and polycystic ovary syndrome management in women in Indian settings
SPONTANEOUS BRAIN ACTIVITY ALTERATIONS REFLECTING MOOD DISORDERS IS ASSOCIATED WITH INSULIN RESISTANCE IN OBESE/OVERWEIGHT WOMEN WITH PCOS
Perspective directions in the treatment of polycystic ovary syndrome (literature review)
Osteopathic approach as an additional therapy of infertility in women with PCOS
Features of correction of metabolic disorders in women with polycystic ovary syndrome
Correction: GnRH antagonist protocol versus progestin-primed ovarian stimulation in patients with polycystic ovary syndrome: a systematic review and meta-analysis
Individualized Treatment of Polycystic Ovary Syndrome Based on Symptom Profile and Patient Characteristics
Androgen Receptors in GABA Neurons Are Required for Increased GABAergic Input to GnRH Neurons but not PCOS Symptoms
Response to the Letter to the Editor by Jorge Violante-Cumpa; Marina Norde & Geloneze Geloneze “Fat-free mass index is a feasible predictor of insulin resistance in women with polycystic ovary syndrome: evidence from a cross-sectional study”
ZAYIF VE OBEZ PCOS’ DA İNSÜLİN REZİSTANSI VE KAN BETATROFİN DÜZEYLERİ ARASINDAKİ İLİŞKİ
Review for "Neuroendocrine mechanisms responsible for elevated <scp>gonadotrophin‐releasing hormone</scp> and luteinising hormone pulses in polycystic ovary syndrome"
OPTIMAL LEADING FOLLICLE SIZE FOR FINAL OOCYTE MATURATION IN ASSISTED REPRODUCTIVE TECHNOLOGY CYCLES OF POLYCYSTIC OVARY SYNDROME PATIENTS
Correlation of Immunological Variables of Interleukin-17 and Heat Shock Protein-70 In Ethnic Women with Polycystic Ovary Syndrome
Relation of Polycystic Ovary Syndrome (PCOS) with Gestational Diabetes Mellitus
Endocrine Alteration Features of Polycystic Ovary Syndrome and Its Impact on Pregnancy